We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
-8.14%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$421M
AUM Growth
-$110M
Cap. Flow
-$66.4M
Cap. Flow %
-15.76%
Top 10 Hldgs %
35.48%
Holding
151
New
7
Increased
29
Reduced
78
Closed
30

Top Sells

Rank Stock Value
1
PLL
PALL CORP
PLL
+$10.3M
2
GE icon
GE Aerospace
GE
+$8.17M
3
DRC
DRESSER-RAND GROUP INC
DRC
+$5.17M
4
ALTR
Altera Corp
ALTR
+$4.47M
5
LLY icon
Eli Lilly
LLY
+$4.23M

Sector Composition

Rank Sector Weight
1 Healthcare 26.28%
2 Technology 19.9%
3 Industrials 17.08%
4 Utilities 8.46%
5 Energy 7.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$599B
$26.4M 6.25%
282,276
-17,508
-6% -$1.69M
GLW icon
2
Corning
GLW
$132B
$20M 4.74%
1,166,847
-40,613
-3% -$731K
KO icon
3
Coca-Cola
KO
$353B
$17M 4.03%
423,797
-20,662
-5% -$828K
XOM icon
4
ExxonMobil
XOM
$615B
$15.7M 3.72%
210,627
-54,819
-21% -$4.22M
PFE icon
5
Pfizer
PFE
$141B
$14.7M 3.49%
493,290
+52,091
+12% +$1.67M
EMR icon
6
Emerson Electric
EMR
$76.5B
$13.1M 3.11%
296,823
-53,125
-15% -$2.61M
INTC icon
7
Intel
INTC
$488B
$11.5M 2.72%
380,625
-21,226
-5% -$614K
SLB icon
8
SLB Ltd
SLB
$69.4B
$10.7M 2.55%
155,535
+14,818
+11% +$1.17M
MRK icon
9
Merck
MRK
$307B
$10.5M 2.49%
223,076
+24,544
+12% +$1.3M
GSK icon
10
GSK
GSK
$100B
$10M 2.38%
208,644
-7,336
-3% -$382K
GVA icon
11
Granite Construction
GVA
$5.34B
$9.62M 2.28%
324,122
+49,735
+18% +$1.67M
LNN icon
12
Lindsay Corp
LNN
$1.15B
$9.44M 2.24%
139,200
+29,112
+26% +$2.31M
BMY icon
13
Bristol-Myers Squibb
BMY
$123B
$9.2M 2.18%
155,329
-4,380
-3% -$278K
GXP
14
DELISTED
Great Plains Energy Incorporated
GXP
$8.68M 2.06%
321,095
-18,680
-5% -$478K
BCE icon
15
BCE
BCE
$20.2B
$8.42M 2%
205,503
-7,650
-4% -$314K
AZTA icon
16
Azenta
AZTA
$1.21B
$7.96M 1.89%
679,392
+60,600
+10% +$653K
IBM icon
17
IBM
IBM
$200B
$7.44M 1.77%
53,696
-12,061
-18% -$1.78M
IDA icon
18
Idacorp
IDA
$8.15B
$7.38M 1.75%
114,110
-4,190
-4% -$253K
CSCO icon
19
Cisco
CSCO
$436B
$7.08M 1.68%
269,865
-15,870
-6% -$429K
HON icon
20
Honeywell
HON
$71.7B
$6.92M 1.64%
81,319
-5,006
-6% -$456K
AMAT icon
21
Applied Materials
AMAT
$417B
$5.92M 1.41%
403,310
+146,500
+57% +$2.45M
OTTR icon
22
Otter Tail
OTTR
$3.83B
$5.71M 1.36%
219,214
+10,036
+5% +$265K
MSFT icon
23
Microsoft
MSFT
$2.99T
$5.48M 1.3%
123,867
-5,970
-5% -$268K
CYT
24
DELISTED
CYTEC INDS INC
CYT
$5.48M 1.3%
74,200
-5,400
-7% -$377K
TT icon
25
Trane Technologies
TT
$103B
$5.22M 1.24%
102,870
+26,200
+34% +$1.57M

Similar funds

John G. Ullman & Associates's Q3 2015 Portfolio in Review

As of Q3 2015, John G. Ullman & Associates held 151 positions worth $421M, down 21% from $531M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

John G. Ullman & Associates withdrew a net $66.4M in Q3 2015, closing 30 positions and reducing 78 holdings. Its most notable exit was PALL CORP, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

Against the trend, John G. Ullman & Associates opened a new position in State Street SPDR S&P Regional Banking ETF worth $2.37M.

  • John G. Ullman & Associates's largest Q3 2015 buy was State Street SPDR S&P Regional Banking ETF: 57,500 shares worth $2.37M.
  • John G. Ullman & Associates added most to Monsanto Co in Q3 2015, an estimated $2.73M increase.
  • John G. Ullman & Associates's biggest Q3 2015 reduction was GE Aerospace, cutting an estimated $8.17M.
  • John G. Ullman & Associates fully exited PALL CORP in Q3 2015, selling an estimated $10.3M.
  • John G. Ullman & Associates's ten largest holdings make up 35% of its $421M portfolio in Q3 2015.
  • John G. Ullman & Associates opened 7 new positions and closed 30 in Q3 2015.
  • John G. Ullman & Associates's portfolio value fell 21% quarter-over-quarter to $421M.

Based on John G. Ullman & Associates's 13F filing for Q3 2015, filed 21 Oct 2015.